NantHealth
NantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. The company's unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine.
History[edit | edit source]
NantHealth was founded in 2007 by Patrick Soon-Shiong, a surgeon, medical researcher, and businessman. The company was established with the aim of revolutionizing the healthcare industry through the use of advanced technology and personalized treatment plans.
Products and Services[edit | edit source]
NantHealth's product portfolio includes a range of software, hardware, and services designed to enable data-driven, evidence-based, personalized healthcare. These include the GPS Cancer test, a unique comprehensive molecular profiling test that helps oncologists to identify the most effective treatment options for cancer patients based on the specific genetic and molecular makeup of their tumors.
The company also offers Eviti, a decision support platform that provides oncologists with access to a comprehensive library of evidence-based treatment options, and NaviNet, a healthcare communication network that enables secure, real-time exchange of information between healthcare providers and payers.
Impact[edit | edit source]
NantHealth's innovative approach to personalized healthcare has the potential to significantly improve patient outcomes and reduce healthcare costs. By integrating molecular data with real-time biometric and phenotypic data, the company's solutions enable more precise and effective treatment decisions, leading to improved patient outcomes and reduced healthcare costs.
Criticism and Controversy[edit | edit source]
Despite its potential, NantHealth has faced criticism and controversy. Some critics argue that the company's products and services are too expensive and that the evidence supporting their effectiveness is insufficient. In addition, the company has faced legal challenges related to its business practices.
See Also[edit | edit source]
References[edit | edit source]
| Professions | |
|---|---|
| Settings | |
| Care | |
| Skills / Training | |
| By country | |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
